Evaluation of Granulosa Cells Function After IVF Protocols
NCT ID: NCT01946022
Last Updated: 2013-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
28 participants
INTERVENTIONAL
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GnRH Agonist
GnRH long agonist protocol of invitro fertilization
randomization between the two GnRH analogues (agonist and antagonist)
GnRH Antagonist
GnRH fixed antagonist protocol of in vitro fertilization
randomization between the two GnRH analogues (agonist and antagonist)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
randomization between the two GnRH analogues (agonist and antagonist)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Follicle Stimulating Hormone (FSH) \< 10 micrometer (mU) / Liter
* Antral follicular count \> 12
* Regular menses (25 to 35 days)
* More than 3 oocytes after ovarian punction
* Anti Mullerian between 1 e 3 ng/ml
Exclusion Criteria
* Ovarian mass or cyst
* Clinical / endocrine pathologies
20 Years
39 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Clinicas de Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Projeto Cegonha
Porto Alegre, Rio Grande do Sul, Brazil
Insemine
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rita d Chapon
Role: primary
Rita
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCPA
Identifier Type: OTHER
Identifier Source: secondary_id
13-0120
Identifier Type: -
Identifier Source: org_study_id